health π¬ JAK inhibitors show promise for alopecia areata patients
Oral Janus kinase (JAK) inhibitors proved effective in promoting hair regrowth for adults and adolescents with moderate-to-severe alopecia areata. Researchers from The Royal Melbourne Hospital, Australia, compared these inhibitors against a placebo across twelve randomized clinical trials. These studies involved 4,141 patients aged 12 or older, including drugs like baricitinib and tofacitinib. JAK inhibitor users showed significantly better results, like achieving SALT less than or equal to 10 at week 24. The team stressed the need for more comparative trials to standardize outcome measures going forward. π¬